Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.

Cancers (Basel) · 2023 · PMC10778564 · PMID 38201475

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

mCRPC patients showed a trend toward a higher number of ctDNA-positive samples when compared to mCSPC, but significance was not reached ( Table 3 , Fisher’s Exact Test, p = 0.08).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.